Skip to main content
search

Regulatory

Sign up

Latest resources

Featured resource

Upcoming regulatory webinars

Latest regulatory blogs

Meet our experts at the following events

Conference

ISSX 2025 International Meeting

September 12 - 14, 2025 – Chicago, Illinois
Conference

ACCP Annual Meeting

September 14 - 16, 2025 – Phoenix, Arizona – Booth #4
Conference

SCDM 2025 Annual Conference

September 27 - 30, 2025

All regulatory resources

Recapping a record-breaking 2025 Krakow HTA Symposium

event, Late clinical - blog, Modeling and Simulation, Blog

Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Case Study

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

Webinar

Three Approaches to AI Adoption in Regulatory Writing

Certara Products, On-Demand Webinar

The end of animal testing? Transitioning to models is promising — but no silver bullet

Certara Products - Simcyp, Homepage Latest, Modeling and Simulation, Press Coverage

Streamline Your Regulatory Writing with Process Infographics

Certara Services, Press Coverage

Building PK/PD Workflows with Cloud and AI – APAC Webinar

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Webinar

SDTM Specification Management

Certara Products - Pinnacle 21, Fact Sheet

MIDD can ease pediatric & rare disease drug loss in Japan

Certara Services, Clinical Pharmacology, Model Informed Drug Development, Modeling and Simulation, Pediatrics, Blog

Pirana Tips and Tricks – Report Object Generation in Pirana

Certara Products, Webinar

SCDM 2025 Annual Conference

Certara Products - Pinnacle 21, Conference

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

Certara Products, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Blog
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.